OTC Zantac name recognition will help overcome late market entry, consultant predicts.

OTC ZANTAC NAME RECOGNITION WILL HELP OVERCOME LATE MARKET ENTRY, KLINE & CO. Healthcare Practice Manager Kathryn Greengrove Griffie predicted at a May 17 session of an Rx-to-OTC switch conference sponsored by International Business Communications in Washington, D.C. Griffie prophesied that sales of an OTC version of Glaxo Wellcome's Zantac H2-antagonist "will be significant" because "brand recognition for Zantac is huge."